<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        116-186-00
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2000
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        JULMENTIN 375 MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMOXICILLIN,CLAVULANIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        250,125
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        23.95
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01CR02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Julmentin </strong>is an antibiotic and works by killing bacteria that cause infections.&nbsp; It contains two different medicines called amoxicillin and clavulanic acid.&nbsp; Amoxicillin belongs to a group of medicines called &ldquo;penicillins&rdquo; that can sometimes be stopped from working (made inactive). The other active component (clavulanic acid) stops this from happening.</p><p><strong>Julmentin </strong>is used in adults and children to treat the following infections:</p><p>&middot;&nbsp; middle ear and sinus infections</p><p>&middot;&nbsp; respiratory tract infections</p><p>&middot;&nbsp; urinary tract infections</p><p>&middot;&nbsp; skin and soft tissue infections including dental infections</p><p>&middot;&nbsp; bone and joint infections.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Julmentin: </strong></p><p>&bull;&nbsp; if you are allergic to amoxicillin, clavulanic acid, penicillin or any of the other ingredients of this medicine<strong> </strong>(listed in section 6)</p><p>&bull;&nbsp; if you have ever had a severe allergic reaction to any other antibiotic. This can include a skin rash or swelling of the face or throat.</p><p>&bull;&nbsp; if you have ever had liver problems or jaundice (yellowing of the skin) when taking an antibiotic.</p><p><strong>Do not take Julmentin if any of the above apply to you.</strong> If you are not sure, talk to your doctor or pharmacist before taking <strong>Julmentin</strong>.</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking this medicine if you:</p><p>&bull;&nbsp; have glandular fever</p><p>&bull;&nbsp; are being treated for liver or kidney problems</p><p>&bull;&nbsp; are not passing water regularly.&nbsp;</p><p>If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking <strong>Julmentin</strong>.</p><p>In some cases, your doctor may investigate the type of bacteria that is causing your infection.&nbsp; Depending on the results, you may be given a different strength of <strong>Julmentin </strong>or a different medicine.</p><p><strong>Conditions you need to look out for&nbsp; </strong></p><p><strong>Julmentin </strong>can make some existing conditions worse, or cause serious side effects.&nbsp; These include allergic reactions, convulsions (fits) and inflammation of the large intestine.&nbsp; You must look out for certain symptoms while you are taking <strong>Julmentin</strong>, to reduce the risk of any problems. See <em>&lsquo;Conditions you need to look out for&rsquo;</em> in <strong>Section 4. </strong></p><p><strong>Blood and urine tests </strong></p><p>If you are having blood tests (such as red blood cell status tests or liver function tests) or urine tests (for glucose), let the doctor or nurse know that you are taking <strong>Julmentin</strong>. This is because <strong>Julmentin </strong>can affect the results of these types of tests.</p><p><strong>Other medicines and Julmentin</strong></p><p>Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.</p><p>&bull;&nbsp; If you are taking allopurinol (used for gout) with <strong>Julmentin</strong>, it may be more likely that you will have an allergic skin reaction.</p><p>&bull;&nbsp; If you are taking probenecid (used for gout), your doctor may decide to adjust your dose of <strong>Julmentin</strong>.&nbsp;</p><p>&bull;&nbsp; If medicines to help stop blood clots (such as warfarin) are taken with <strong>Julmentin</strong> then extra blood tests may be needed.</p><p>&bull;&nbsp; <strong>Julmentin</strong> can affect how methotrexate (a medicine used to treat cancer or rheumatic diseases) works.</p><p>&bull;&nbsp; <strong>Julmentin</strong> can affect how mycophenolate mofetil (a medicine used to prevent the rejection of transplanted organs) works.</p><p><strong>Pregnancy, breast-feeding and fertility </strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.&nbsp;</p><p><strong>Driving and using machines </strong></p><p><strong>Julmentin </strong>can have side effects and the symptoms may make you unfit to drive.</p><p>Don&rsquo;t drive or operate machinery unless you are feeling well.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine<strong> </strong>exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p><strong><u>Adults and children weighing 40 kg and over</u></strong></p><p><strong>Julmentin 375mg and Julmentin</strong><strong> Forte</strong><strong> 625mg tablets:</strong></p><p>The usual dose is: 1 tablet three times a day.</p><p><strong>Julmentin &nbsp;</strong><strong>2X</strong><strong> 1000mg tablets:</strong></p><p>Usual dose &ndash; 1 tablet two times a day.</p><p>Higher dose &ndash; 1 tablet three times a day.&nbsp;</p><p><strong><u>Children weighing less than 40 kg</u></strong><strong> </strong></p><p>Children aged 6 years or less should preferably be treated with <strong>Julmentin </strong>oral suspension.</p><p>Ask your doctor or pharmacist for advice when giving <strong>Julmentin </strong>tablets to children weighing less than 40 kg. The tablets are not suitable for children weighing less than 25 kg.</p><p><strong>Patients with kidney and liver problems<em> </em></strong></p><p>&bull;&nbsp; If you have kidney problems the dose might be changed.&nbsp; A different strength or a different medicine may be chosen by your doctor.&nbsp;&nbsp;&nbsp;</p><p>&bull;&nbsp; If you have liver problems you may have more frequent blood tests to check how your liver is working.</p><p><strong>How to take Julmentin &nbsp;</strong></p><p>&bull;&nbsp; Take with a meal.</p><p>&bull;&nbsp; Swallow the tablets whole with a glass of water.</p><p>&bull;&nbsp; Space the doses evenly during the day, at least 4 hours apart.&nbsp; Do not take 2 doses in 1 hour.</p><p>&bull;&nbsp; Do not take <strong>Julmentin</strong> for more than 2 weeks. If you still feel unwell you should go back to see the doctor.</p><p><strong>If you take more Julmentin than you should</strong></p><p>If you have too much <strong>Julmentin</strong>, signs might include an upset stomach (feeling sick, being sick or diarrhoea) or convulsions. Talk to your doctor as soon as possible. Take the medicine carton to show the doctor.</p><p><strong>If you forget to take Julmentin &nbsp;</strong></p><p>If you forget to take a dose, take it as soon as you remember. You should not take the next dose too soon, but wait about 4 hours before taking the next dose. Do not take a double dose to make up for a forgotten dose.</p><p><strong>If you stop taking Julmentin &nbsp;</strong></p><p>Keep taking <strong>Julmentin </strong>until the treatment is finished, even if you feel better. You need every dose to help fight the infection. If some bacteria survive they can cause the infection to come back.</p><p><strong>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine<strong> </strong>can cause side effects, although not everybody gets them.</p><p>The side effects below may happen with this medicine.</p><p><strong>Conditions you need to look out for&nbsp; </strong></p><p><strong>Allergic reactions:&nbsp; </strong></p><p>&bull;&nbsp; skin rash</p><p>&bull;&nbsp; inflammation of blood vessels (vasculitis) which may be visible as red or purple raised spots on the skin, but can affect other parts of the body</p><p>&bull;&nbsp; fever, joint pain, swollen glands in the neck, armpit or groin&nbsp;</p><p>&bull;&nbsp; swelling, sometimes of the face or throat (angioedema), causing difficulty in breathing</p><p>&bull;&nbsp; collapse.</p><p><strong>Contact a doctor immediately </strong>if you get any of these symptoms.<strong> Stop taking</strong> <strong>Julmentin. </strong></p><p><strong>Inflammation of large intestine</strong></p><p>Inflammation of the large intestine, causing watery diarrhoea usually with blood and mucus, stomach pain and/or fever.</p><p><strong>Contact your doctor as soon as possible </strong>for advice if you get these symptoms.</p><p><strong>Very common side effects </strong></p><p>These may affect more than 1 in 10 people&nbsp;</p><p>&bull;&nbsp; diarrhoea (in adults).</p><p><strong>Common side effects </strong></p><p>These may affect up to 1 in 10 people</p><p>&bull;&nbsp; thrush (candida - a yeast infection of the vagina, mouth or skin folds)</p><p>&bull;&nbsp; feeling sick (nausea), especially when taking high doses, if affected take <strong>Julmentin</strong> with a meal &nbsp;</p><p>&bull;&nbsp; vomiting&nbsp;</p><p>&bull;&nbsp; diarrhoea (in children).&nbsp;</p><p><strong>Uncommon</strong> <strong>side effects </strong></p><p>These may affect up to 1 in 100 people&nbsp;</p><p>&bull;&nbsp; skin rash, itching&nbsp;</p><p>&bull;&nbsp; raised itchy rash (hives)</p><p>&bull;&nbsp; indigestion&nbsp;</p><p>&bull;&nbsp; dizziness</p><p>&bull;&nbsp; headache.</p><p>Uncommon side effects that may show up in your blood tests:</p><p>&bull;&nbsp; increase in some substances (enzymes) produced by the liver.</p><p><strong>Rare side effects </strong></p><p>These may affect up to 1 in 1000 people<strong>&nbsp; </strong></p><p>&bull;&nbsp; skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge &ndash; <em>erythema multiforme</em>)</p><p>If you notice any of these symptoms contact a doctor urgently.</p><p>Rare side effects that may show up in your blood tests:</p><p>&bull;&nbsp; low number of cells involved in blood clotting&nbsp;</p><p>&bull;&nbsp; low number of white blood cells.</p><p><strong>Frequency not known</strong></p><p>Frequency cannot be estimated from the available data.</p><p>&bull; Allergic reactions (see above)</p><p>&bull; Inflammation of the large intestine (see above)</p><p>&bull; Inflammation of the protective membrane surrounding the brain (<em>aseptic meningitis</em>)</p><p>&bull; Serious skin reactions:</p><p>-&nbsp; a widespread rash with blisters and peeling skin, particularly around the mouth, nose,&nbsp; eyes and genitals</p><p>(<em>Stevens-Johnson syndrome</em>), and a more severe form, causing extensive peeling of the skin (more than 30% of the body surface &ndash; <em>toxic epidermal necrolysis</em>)</p><p>-&nbsp; widespread red skin rash with small pus-containing blisters (<em>bullous exfoliative&nbsp; dermatitis</em>)</p><p>-&nbsp; a red, scaly rash with bumps under the skin and blisters (<em>exanthemous pustulosis</em>).</p><p>-&nbsp; flu-like symptoms with a rash, fever, swollen glands, and abnormal blood test results (including increased white blood cells (eosinophilia) and liver enzymes) (Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)).</p><p><strong>Contact a doctor immediately if you get any of these symptoms.&nbsp;&nbsp; </strong></p><p>&bull; inflammation of the liver (<em>hepatitis)</em></p><p>&bull; jaundice, caused by increases in the blood of bilirubin (a substance produced in the liver) which may make your skin and whites of the eyes appear yellow&nbsp;</p><p>&bull; inflammation of tubes in the kidney</p><p>&bull;&nbsp; blood takes longer to clot</p><p>&bull; hyperactivity</p><p>&bull; convulsions (in people taking high doses of <strong>Julmentin </strong>or who have kidney problems)</p><p>&bull; black tongue which looks hairy&nbsp;</p><p>Side effects that may show up in your blood or urine tests:</p><p>&bull; severe reduction in the number of white blood cells</p><p>&bull; low number of red blood cells (haemolytic anaemia)</p><p>&bull; crystals in urine.</p><p><strong>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</strong></p><p><br /><strong><u>To report any side effect(s): </u></strong></p><p><strong>&bull; Saudi Arabia: </strong></p><p><strong>&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC):</strong></p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp; - SFDA Call Centre: </strong>19999</p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp; - E-mail: </strong>npc.drug@sfda.gov.sa</p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp; - Website: </strong>https://ade.sfda.gov.sa/</p><p><strong>&bull; Other GCC States: </strong></p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</strong> Please contact the relevant competent authority.</p><p>By reporting side effects, you can help provide more information on the safety of this medicine</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp;&nbsp; Store below 30&ordm;C, in a dry place.</p><p>-&nbsp;&nbsp; Do not take <strong>Julmentin </strong>after the expiry date which is stated on the carton and on the blister.</p><p>-&nbsp;&nbsp; Do not take <strong>Julmentin </strong>if you notice any visible sign of deterioration.</p><p>-&nbsp;&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What </strong><strong>Julmentin </strong><strong>contains </strong></p><p>The active substance is Amoxicillin and clavulanic acid.</p><p><strong>Julmentin </strong><strong>Tablets 375mg: </strong>Each tablet contains:</p><p><em>Active ingredients:</em> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amoxicillin 250mg as amoxicillin trihydrate and clavulanic acid 125mg as potassium clavulanate.</p><p><em>Excipients</em>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Colloidal silicon dioxide, crospovidone, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, ethyl cellulose, titanium dioxide, polishing emulsion, PVP K-25, hydroxypropyl cellulose, talc, and triacetin.&nbsp;</p><p><strong>Julmentin</strong> <strong>Forte</strong> <strong>Tablets </strong><strong>625mg</strong><strong>:</strong> Each tablet contains:</p><p><em>Active ingredients</em><em>:</em> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amoxicillin 500mg as amoxicillin trihydrate and clavulanic acid 125mg as potassium clavulanate.</p><p><em>Excipients</em>: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Colloidal silicon dioxide, crospovidone, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, hydroxypropyl cellulose, talc, triacetin, PVP K-25, titanium dioxide, polishing agent and ethyl cellulose.&nbsp;</p><p><strong>Julmentin</strong> <strong>2X</strong> <strong>Tablets 1000mg: </strong>Each tablet contains:</p><p><em>Active ingredients</em><em>:</em> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amoxicillin 875mg as amoxicillin trihydrate and clavulanic acid 125mg as potassium clavulanate.</p><p><em>Excipients</em>: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Colloidal silicon dioxide, crospovidone, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, hydroxypropyl cellulose, ethyl cellulose, PVP K-25, triacetin EV, titanium dioxide, talc and polishing emulsion.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Julmentin and Julmentin Forte tablets:     Pack of 15 tablets or 20 tablets.
Julmentin 2X tablets:                                    Pack of 15 tablets.
Not all pack sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                

18/03/2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">إن <strong>جلمنتين </strong>عبارة عن مضاد حيوي ويعمل عن طريق قتل البكتيريا التي تسبب العدوى. ويحتوي على نوعين مختلفين من الدواء هما أموكسيسيلين وحمض كلافيولانيك. ينتمي أموكسيسيلين إلى مجموعة الأدوية التي يطلق عليها &quot;البنسيلينات&quot; والذي في بعض الأحيان قد يتعرض لمقاومة بكتيرية تفقده مفعوله (تكبح نشاطه). يقوم المكون الآخر النشط&nbsp; في هذا المستحضر وهو (حمض كلافيولانيك) بكبح هذه المقاومة.</p><p dir="RTL">يستخدم <strong>جلمنتين </strong>للبالغين والأطفال لعلاج أنواع العدوى التالية:</p><p dir="RTL">&bull;&nbsp; عدوى الأذن الوسطى وعدوى الجيوب الأنفية</p><p dir="RTL">&bull;&nbsp; عدوى الجهاز التنفسي</p><p dir="RTL">&bull;&nbsp; عدوى المسالك البولية</p><p dir="RTL">&bull;&nbsp; عدوى الجلد والأنسجة الرخوة بما في ذلك عدوى الأسنان</p><p dir="RTL">&bull;&nbsp; عدوى العظام والمفاصل.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عدم تناول جلمنتين في الحالات التالية:</strong></p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من الحساسية تجاه أموكسيسيلين، حمض الكلافيولانيك، البنسيلين أو تجاه أياً من المكونات الأخرى في <strong>جلمنتين</strong> (المذكورة في البند رقم 6).</p><p dir="RTL">&bull;&nbsp; إذا كنت قد تعرضت مسبقاً لتفاعل تحسسي شديد لأي من المضادات الحيوية الأخرى. وقد يشمل ذلك حدوث طفح جلدي أو تورم في الوجه أو الحلق.</p><p dir="RTL">&bull;&nbsp; إذا عانيت مسبقاً من اضطرابات في الكبد أو اليرقان (اصفرار الجلد) عند تناول أياً من المضادات الحيوية.</p><p dir="RTL"><strong>يجب عدم تناول</strong> <strong>جلمنتين إذا كان أياً مما ذكر أعلاه ينطبق عليك. </strong>يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول<strong> جلمنتين</strong>، إذا لم تكن متأكداً من ذلك.</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول هذا الدواء إذا كنت:</p><p dir="RTL">&bull;&nbsp; تعاني من حمى غدية</p><p dir="RTL">&bull;&nbsp; تتلقى علاجاً لاضطرابات في الكبد أو الكلى</p><p dir="RTL">&bull;&nbsp; تعاني من حالة تتمثل في عدم إدرار البول بصورة طبيعية.</p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول<strong> جلمنتين</strong>، في حال لم تكن متأكداً ما إذا كان أياً مما ذكر أعلاه ينطبق عليك.</p><p dir="RTL">في بعض الحالات، قد يقوم طبيبك المعالج بإجراء فحص مختبري لمعرفة نوع البكتيريا المسببة للعدوى. وبناءً على نتائج هذا الفحص، قد يعطى لك <strong>جلمنتين </strong>بتركيز مختلف أو قد يصف لك دواء آخر.</p><p dir="RTL"><strong>الحالات التي تتطلب منك الانتباه</strong></p><p dir="RTL">قد يسبب <strong>جلمنتين </strong>تفاقم بعض الحالات المرضية الكامنة. كما قد يسبب في حدوث تأثيرات جانبية خطيرة، والتي تتضمن على تفاعلات تحسسية، تشنجات (اختلاجات) والتهاب في الأمعاء الغليظة. يجب الانتباه لمثل هذه الأعراض التي قد تحدث أثناء فترة تناول <strong>جلمنتين</strong>، للتقليل من خطر حدوث أية مشاكل. انظر &quot; الحالات التي تتطلب منك الانتباه&quot;<strong> </strong>في<strong> البند رقم 4</strong>.</p><p dir="RTL"><strong>فحوصات الدم أو البول</strong></p><p dir="RTL">إذا كنت ستخضع لفحوصات الدم (مثل فحوصات خلايا الدم الحمراء أو فحوصات وظائف الكبد) أو فحوصات البول (للكشف عن الجلوكوز)، فإنه يجب عليك إخبار الطبيب المعالج أو الممرض بأنك تتناول<strong> جلمنتين</strong>، وذلك لأن <strong>جلمنتين </strong>يمكن أن يؤثر على نتائج هذه فحوصات .</p><p dir="RTL"><strong>تناول </strong><strong>جلمنتين بالتزامن </strong><strong>مع الأدوية الأخرى</strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول، تناولت مؤخراً أو قد تتناول أية أدوية أخرى.</p><p dir="RTL">&bull;&nbsp; إذا كنت تتناول ألوبيورينول (دواء يستخدم لعلاج النقرس) بالتزامن مع <strong>جلمنتين</strong>، فإنه من المرجح حدوث تفاعل تحسسي جلدي.</p><p dir="RTL">&bull;&nbsp; إذا كنت تتناول بروبنسيد (دواء يستخدم لعلاج النقرس)، فقد يقرر طبيبك المعالج تعديل جرعة <strong>جلمنتين</strong>.</p><p dir="RTL">&bull;&nbsp; إذا كنت تتناول الأدوية التي تمنع تكون الخثرات في الدم (على سبيل المثال الوارفارين) بالتزامن مع <strong>جلمنتين</strong> فقد يحتاج الطبيب المعالج إلى إجراء فحوصات دموية إضافية.</p><p dir="RTL">&bull;&nbsp; قد يؤثر <strong>جلمنتين</strong> على آلية عمل ميثوتركسات (دواء يستخدم لعلاج السرطان أو الأمراض الروماتيزمية).</p><p dir="RTL">&bull;&nbsp; كما قد يؤثر <strong>جلمنتين</strong> على آلية عمل مايكوفينولات موفيتل (دواء يستخدم لمنع رفض الجسم لعمليات زراعة الأعضاء).</p><p dir="RTL"><strong>الحمل، الرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">إذا كنت حاملاً أو ترضعين طفلك رضاعة طبيعية، تعتقدين بأنك حاملاً أو تخططين لإنجاب طفلاً، فيرجى استشارة طبيبك المعالج أو الصيدلي الذي تتعاملين معه للحصول على النصيحة قبل تناول هذا الدواء .</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد يسبب <strong>جلمنتين </strong>في حدوث تأثيرات جانبية وأعراض والتي يمكن أن تعيق قدرتك على القيادة.</p><p dir="RTL">يجب عدم القيادة أو تشغيل الآلات ما لم تكن بصحة جيدة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك دائماً تناول <strong>جلمنتين </strong>بدقة وفقاً لتعليمات طبيبك المعالج أو الصيدلي الذي تتعامل معه. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا لم تكن متأكداً.</p><p dir="RTL"><strong><u>البالغين والأطفال الذين تبلغ أوزانهم 40 كيلوغرام أو أكثر</u></strong></p><p dir="RTL"><strong>أقراص جلمنتين 375 ملغم و أقراص جلمنتين فورت 625 ملغم:</strong></p><p dir="RTL">الجرعة الاعتيادية هي: قرص واحد ثلاث مرات يومياً.</p><p dir="RTL"><strong>أقراص جلمنتين</strong> <strong>2 إكس 1000 ملغم:</strong></p><p dir="RTL">الجرعة الاعتيادية- قرص واحد مرتين يومياً.</p><p dir="RTL">الجرعة الأعلى- قرص واحد ثلاث مرات يومياً.</p><p dir="RTL"><strong><u>الأطفال الذين تقل أوزانهم عن 40 كيلوغرام</u></strong></p><p dir="RTL">يفضل إعطاء معلق <strong>جلمنتين</strong> الفموي للأطفال بعمر 6 سنوات أو أقل.</p><p dir="RTL">يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل إعطاء أقراص <strong>جلمنتين</strong> للأطفال الذين تبلغ أوزانهم أقل من 40 كيلوغرام. إن الأقراص غير مناسبة للأطفال الذين تبلغ أوزانهم أقل من 25 كيلوغرام.</p><p dir="RTL"><strong>المرضى الذين يعانون من اضطرابات في الكلى والكبد</strong></p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من اضطرابات في الكلى فإنه يمكن استخدام تركيز مختلف أو اختيار دواء مختلف من قبل طبيبك المعالج. &nbsp;</p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من اضطرابات في الكبد، فإنه قد يلزم إجراء فحوصات للدم بشكل دوري لمعرفة مدى كفاءة وظائف الكبد.</p><p dir="RTL"><strong>كيفية إعطاء جلمنتين </strong></p><p dir="RTL">&bull;&nbsp; يرجى منك تناول هذا الدواء مع وجبة الطعام.</p><p dir="RTL">&bull;&nbsp; ابلع الأقراص كاملةً مع كوباً من الماء.</p><p dir="RTL">&bull;&nbsp; قم بترك فترة متساوية بين كل جرعة وأخرى خلال اليوم، بحيث لا تقل عن 4 ساعات. يجب عدم تناول جرعتين خلال ساعة واحدة.</p><p dir="RTL"><strong>&bull;&nbsp; </strong>يجب عدم تناول <strong>جلمنتين</strong> لأكثر من أسبوعين. يجب عليك الذهاب لرؤية الطبيب المعالج مرة أخرى، في حال الاستمرار في الشعور بالإعياء.</p><p dir="RTL"><strong>إذا تناولت </strong><strong>جلمنتين </strong><strong>بجرعة أكبر مما يجب </strong></p><p dir="RTL">إذا كنت قد تناولت <strong>جلمنتين </strong>بجرعة أكبر مما يجب، فإن ذلك قد يؤدي إلى ظهور علامات تشمل اضطراب في المعدة (الشعور بالإعياء، توعك أو إسهال) أو اختلاجات. يرجى منك إخبار طبيبك المعالج بهذا الأمر في أسرع وقت ممكن. خذ عبوة الدواء لإظهارها للطبيب المعالج.</p><p dir="RTL"><strong>إذا سهوت عن تناول </strong><strong>جلمنتين </strong></p><p dir="RTL">إذا سهوت عن تناول إحدى جرعات <strong>جلمنتين</strong>، فيجب عليك تناولها في أسرع وقت ممكن حال تذكرها. أما الجرعة التالية فيجب عدم تناولها في الحال ولكن يجب الانتظار مدة 4 ساعات تقريباً قبل تناول الجرعة التالية. يجب عليك عدم تناول جرعة مضاعفة لتعويض الجرعة التي قد سهوت عنها.</p><p dir="RTL"><strong>إذا توقفت عن تناول</strong><strong> </strong><strong>جلمنتين </strong></p><p dir="RTL">استمر في تناول <strong>جلمنتين </strong>إلى انتهاء دورة العلاج المقررة، حتى لو تحسنت حالتك. حيث أنك بحاجة إلى كل جرعة من الجرعات الموصوفة لك للقضاء على العدوى. إذا لم يتم القضاء على جميع البكتيريا المسببة للعدوى فقد تعاود العدوى مرة أخرى.</p><p dir="RTL"><strong>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا كان لديك أية أسئلة إضافية حول استعمال هذا الدواء.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع جميع الأدوية، قد يسبب <strong>جلمنتين</strong> تأثيرات جانبية، بالرغم من أنها قد لا تحدث لكل شخص. قد تحدث التأثيرات الجانبية التالية أثناء فترة تناول هذا الدواء.</p><p dir="RTL"><strong>الحالات التي تتطلب منك الانتباه</strong></p><p dir="RTL"><strong>&nbsp;التفاعلات التحسسية:</strong></p><p dir="RTL">&bull;&nbsp; طفح جلدي</p><p dir="RTL">&bull;&nbsp; التهاب الأوعية الدموية الذي يظهر بشكل بقع حمراء أو أرجوانية مرتفعة عن سطح الجلد، ولكن قد يؤثر على الأجزاء الأخرى من الجسم</p><p dir="RTL">&bull;&nbsp; حمى، ألم في المفاصل، تورم الغدد في منطقة العنق، الفخذين أو الإبطين</p><p dir="RTL">&bull;&nbsp; تورم في بعض الأحيان يشمل الوجه أو الحلق (وذمة وعائية)، مسببة صعوبة في التنفس</p><p dir="RTL">&bull;&nbsp; تدهور عام في الصحة.</p><p dir="RTL"><strong>يرجى منك التواصل مع الطبيب المعالج مباشرةً </strong>في حال تعرضت لأي من هذه الأعراض. <strong>يرجى منك التوقف عن تناول جلمنتين في حال حدوث ذلك.</strong></p><p dir="RTL"><strong>التهاب الأمعاء الغليظة</strong></p><p dir="RTL">التهاب الأمعاء الغليظة، والذي قد يؤدي إلى إسهال مائي مصحوب عادةً بدم أو مخاط، ألم في المعدة و/أو حمى.</p><p dir="RTL"><strong>يرجى منك التواصل مع طبيبك </strong><strong>المعالج</strong><strong> </strong><strong>في أسرع وقت ممكن</strong> للحصول على النصيحة في حال تعرضك لأي من هذه الأعراض. &nbsp;</p><p dir="RTL"><strong>تأثيرات جانبية شائعة جداً</strong></p><p dir="RTL">قد تصيب أكثر من شخص واحد من كل &nbsp;10 أشخاص</p><p dir="RTL">&bull;&nbsp; إسهال (لدى البالغون).</p><p dir="RTL"><strong>تأثيرات جانبية شائعة</strong></p><p dir="RTL">قد تصيب حتى شخص واحد من كل &nbsp;10 أشخاص&nbsp;</p><p dir="RTL">&bull;&nbsp; داء القلاع (الكانديدا &ndash; عدوى الخميرة في المهبل، الفم أو الثنايا الجلدية)</p><p dir="RTL">&bull;&nbsp; الشعور بإعياء (غثيان)، وبصفة خاصة عند تناول جرعات عالية، وفي حال الإصابة بذلك ينصح بتناول <strong>جلمنتين</strong> مع الطعام</p><p dir="RTL">&bull;&nbsp; تقيؤ</p><p dir="RTL">&bull;&nbsp; إسهال (لدى الأطفال).</p><p dir="RTL"><strong>تأثيرات جانبية غير شائعة</strong></p><p dir="RTL">قد تصيب حتى شخص واحد من كل &nbsp;100 شخص&nbsp;</p><p dir="RTL">&bull;&nbsp; طفح جلدي، حكة</p><p dir="RTL">&bull;&nbsp; طفح جلدي مصحوب بحكة (طفح جلدي على شكل خلايا النحل)</p><p dir="RTL">&bull;&nbsp; عسر الهضم</p><p dir="RTL">&bull;&nbsp; دوخة</p><p dir="RTL">&bull;&nbsp; صداع.</p><p dir="RTL">تأثيرات جانبية غير شائعة قد تظهر عند إجراء فحوصات الدم:</p><p dir="RTL">&bull;&nbsp; زيادة في بعض المواد (الإنزيمات) التي يتم إنتاجها بواسطة الكبد.</p><p dir="RTL"><strong>تأثيرات جانبية نادرة</strong></p><p dir="RTL">قد تصيب مايصل إلى شخص واحد من كل &nbsp;1000 شخص</p><p dir="RTL">&bull;&nbsp; طفح جلدي، قد يتحول إلى بثور، ويبدو على هيئة أقراص دائرية صغيرة (بقع داكنة في المركز محاطة بمنطقة شاحبة اللون، مع وجود حلقة داكنة حول الأطراف &ndash; حمامى متعددة الأشكال)</p><p dir="RTL">يرجى منك التواصل مع الطبيب المعالج على الفور، إذا لاحظت أياً من هذه الأعراض.</p><p dir="RTL">تأثيرات جانبية نادرة قد تظهر عند إجراء فحوصات الدم:</p><p dir="RTL">&bull;&nbsp; انخفاض تعداد الخلايا المساهمة في عملية تخثر الدم</p><p dir="RTL">&bull;&nbsp; انخفاض تعداد خلايا الدم البيضاء.</p><p dir="RTL"><strong>غير معروفة التكرار</strong></p><p dir="RTL">لا يمكن تحديد معدل تكرار حدوثها من البيانات المتاحة.</p><p dir="RTL">&bull;&nbsp; تفاعلات تحسسية (انظر أعلاه)</p><p dir="RTL">&bull;&nbsp; التهاب الأمعاء الغليظة (انظر أعلاه)</p><p dir="RTL">&bull;&nbsp; التهاب الغشاء الواقي المحيط بالدماغ (التهاب السحايا العقيم)</p><p dir="RTL">&bull;&nbsp; تفاعلات جلدية خطيرة:</p><p dir="RTL">-&nbsp; &nbsp;طفح جلدي منتشر مع بثور وتقشر في الجلد، وصفة خاصة حول الفم، الأنف، العينين والأعضاء التناسلية (متلازمة ستيفنن-جونسون)، وقد يؤدي &nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&nbsp;النوع الأكثر خطورة من هذا المرض إلى حدوث تقشر في مساحات واسعة من الجلد (أكثر من 30٪ من سطح الجسم- انحلال البشرة السمي&nbsp;</p><p dir="RTL">&nbsp;التنخري).</p><p dir="RTL">-&nbsp; &nbsp;طفح جلدي منتشر أحمر اللون مع بثور صغيرة متقيحة (التهاب الجلد التقشري الفقاعي)</p><p dir="RTL">-&nbsp; &nbsp;طفح جلدي مصحوباً بتقشر الجلد أحمر اللون مع نتوءات تحت الجلد وبثور (بثار طفحي متقيح على الجلد).</p><p dir="RTL">-&nbsp; أعراض شبيهة بأعراض الإنفلونزا&nbsp;مصحوباً بحدوث طفح جلدي، حمى، تورم الغدد ونتائج فحوصات الدم الغير طبيعية (بما في ذلك ارتفاع مستوى خلال الدم البيضاء (فرط اليوزينيات) وأنزيمات الكبد) (التفاعل الدوائي المصحوب بفرط اليوزينيات والأعراض الجهازية).</p><p dir="RTL"><strong>يرجى منك التواصل مع الطبيب المعالج مباشرةً إذا تعرضت لأي من هذه الأعراض.</strong></p><p dir="RTL">&bull;&nbsp; التهاب الكبد</p><p dir="RTL">&bull;&nbsp; يرقان، ناتج عن زيادة البليروبين في الدم (مادة مفرزة من الكبد) وقد يؤدي إلى تلون الجلد وبياض العينين باللون الأصفر</p><p dir="RTL">&bull;&nbsp; التهاب الأنابيب في الكلى</p><p dir="RTL">&bull;&nbsp; طول الفترة اللازمة لتخثر الدم</p><p dir="RTL">&bull;&nbsp; فرط النشاط</p><p dir="RTL">&bull;&nbsp; اختلاجات (لدى المرضى الذين يتناولون جرعات عالية من هذا الدواء<strong> </strong>أو الذين يعانون من اضطرابات في الكلى)</p><p dir="RTL">&bull;&nbsp; لسان أسود ومشعر</p><p dir="RTL">تأثيرات جانبية قد تظهر عند إجراء فحوصات للدم أو البول:</p><p dir="RTL">&bull;&nbsp; انخفاض شديد في تعداد خلايا الدم البيضاء</p><p dir="RTL">&bull;&nbsp; انخفاض تعداد خلايا الدم الحمراء (فقر الدم الإنحلالي)</p><p dir="RTL">&bull;&nbsp; ظهور البلورات في البول</p><p dir="RTL"><strong>يرجى </strong><strong>منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه، في حال حدوث أياً من التأثيرات الجانبية بما في ذلك أية تأثيرات جانبية يحتمل حدوثها ولم يتم ذكرها في هذه النشرة. </strong></p><p dir="RTL"><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong><br /><strong>&bull; &nbsp;المملكة العربية السعودية:</strong></p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ الدوائي:</strong></p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - مركز الاتصال الموحد: </strong>19999</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - البريد الإلكتروني:&nbsp; </strong>npc.drug@sfda.gov.sa</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -<strong> الموقع الإلكتروني:</strong>&nbsp; https://ade.sfda.gov.sa/</p><p dir="RTL"><strong>&bull; دول الخليج العربي الأخرى: </strong></p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </strong>الرجاء الاتصال بالجهات الوطنية في كل دولة.</p><p dir="RTL">إن الإبلاغ عن التأثيرات الجانبية يساعد في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من &ordm;30م، في مكان جاف.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يجب عدم تناول <strong>جلمنتين </strong>بعد تاريخ انتهاء الصلاحية المذكور على العبوة &nbsp;والشريط.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يجب عدم تناول <strong>جلمنتين </strong>إذا لاحظت وجود علامات تلف واضحة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ماهي محتويات </strong><strong>جلمنتين </strong></p><p dir="RTL">المادة الفعالة هي: أموكسيسيلين وحمض كلافيولانيك.</p><p dir="RTL"><strong>جلمنتين أقراص 375 ملغم: </strong>يحتوي كل قرص على:</p><p dir="RTL">المواد الفعالة:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أموكسيسيلين 250 ملغم على هيئة أموكسيسيلين ثلاثي الهيدرات وحمض كلافيولانيك 125 ملغم على هيئة كلافيولانات البوتاسيوم.</p><p dir="RTL">المواد غير الفعالة:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ثنائي أكسيد السيليكون الغروي، كروس بوفيدون، كروس كارميلوز الصوديوم، استيارات المغنيسيوم، سليلوز دقيق البلورات، إثيل السليلوز، ثنائي أكسيد التيتانيوم، مستحلب للصقل، بولي فينيل بايروليدون كي-25، هيدروكسي بروبيل السليلوز، تلك، وتراي أسيتين.</p><p dir="RTL"><strong>جلمنتين فورت أقراص 625 ملغم: </strong>يحتوي كل قرص على:</p><p dir="RTL">المواد الفعالة:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أموكسيسيلين 500 ملغم على هيئة أموكسيسيلين ثلاثي الهيدرات وحمض كلافيولانيك 125 ملغم على هيئة كلافيولانات البوتاسيوم.</p><p dir="RTL">المواد غير الفعالة:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ثنائي أكسيد السيليكون الغروي، كروس بوفيدون، كروس كارميلوز الصوديوم، استيارات المغنيسيوم، سليلوز دقيق البلورات، هيدروكسي بروبيل السليلوز، تلك، تراي أسيتين، بولي فينيل بايروليدون كي-25، ثنائي أكسيد التيتانيوم، مستحلب للصقل وإثيل السليلوز.</p><p dir="RTL"><strong>جلمنتين 2 إكس أقراص 1000 ملغم: </strong>يحتوي كل قرص على:</p><p dir="RTL">المواد الفعالة:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أموكسيسيلين 875 ملغم على هيئة أموكسيسيلين ثلاثي الهيدرات وحمض كلافيولانيك 125 ملغم على هيئة كلافيولانات البوتاسيوم.</p><p dir="RTL">المواد غير الفعالة:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ثنائي أكسيد السيليكون الغروي، كروس بوفيدون، كروس كارميلوز الصوديوم، استيارات المغنيسيوم، سليلوز دقيق البلورات، هيدروكسي بروبيل السليلوز، إثيل السليلوز، بولي فينيل بايروليدون كي-25، تراي أسيتين إي في، ثنائي أكسيد التيتانيوم، تلك ومستحلب للصقل.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أقراص<strong> جلمنتين </strong>و<strong>جلمنتين</strong> <strong>فورت</strong>: عبوة تحتوي على 15 أو 20 قرصاً.</p><p dir="RTL">أقراص<strong> جلمنتين 2 إكس</strong>:<strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>عبوة تحتوي على 15 قرصاً.<strong> </strong></p><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية &quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
18/3/2022م

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Julmentin 375mg film-coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains:
Item no.	Material Name	Scale (mg/Tablet)
		
	Active Ingredients:	
1.		Amoxicillin 	250.000
	Use: Amoxicillin Trihydrate	290.000
2.		Clavulanic Acid	125.000
	Use: Potassium Clavulanate mixture# (1:1 with Avicel) equivalent to Clavulanic acid 125mg 	300.000
		
	Inactive Ingredients: 	
1.		Colloidal silicon dioxide (Aerosil-200)	1.000
2.		Crospovidone (Kollidon CL)	10.000
3.		Croscarmellose sodium (Ac-Di-Sol)	10.000
4.		Magnesium stearate 	3.500
5.		Microcrystalline cellulose (Avicel PH-112)	35.500
		
	Coating Materials: 	
1.		Hydroxypropyl cellulose (Klucel EF)	26.000
2.		Ethyl cellulose 	3.000
3.		PVP K 25	0.300
4.		Triacetin  	4.500
5.		Titanium dioxide	9.500
6.		Talc fine powder 	3.625
7.		Polishing emulsion  	2.500
8.		Absolute alcohol*	q.s

*Evaporates during drying process 
q.s: quantity sufficient 
# 10% Excess may be added in batch quantity by considering an allowable limit mentioned in the USP monograph (90.0% to 120.0%) 

For a full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated Tablet.
Description: White to almost white, oval, biconvex, film-coated tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Julmentin</strong> is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1).</p><p>&sect; Acute bacterial sinusitis (adequately diagnosed)</p><p>&sect; Cystitis</p><p>&sect; Pyelonephritis</p><p>&sect; Cellulitis</p><p>&sect; Animal bites</p><p>&sect; Severe dental abscess with spreading cellulitis.</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Posology</u></strong></p><p>Doses are expressed throughout in terms of amoxicillin/clavulanic acid content except when doses are stated in terms of an individual component.</p><p>The dose of <strong>Julmentin</strong> that is selected to treat an individual infection should take into account:</p><p>&sect; The expected pathogens and their likely susceptibility to antibacterial agents (see section 4.4)</p><p>&sect; The severity and the site of the infection</p><p>&sect; The age, weight and renal function of the patient as shown below.</p><p>The use of alternative presentations of amoxicillin/clavulanic acid (e.g. those that provide higher doses of amoxicillin and/or different ratios of amoxicillin to clavulanic acid) should be considered as necessary (see sections 4.4 and 5.1).</p><p>For adults and children &ge; 40 kg, this formulation <strong>Julmentin </strong>provides a total daily dose of 750 mg amoxicillin/375 mg clavulanic acid, when administered as recommended below. If it is considered that a higher daily dose of amoxicillin is required, it is recommended that another preparation of <strong>Julmentin</strong> is selected in order to avoid administration of unnecessarily high daily doses of clavulanic acid (see sections 4.4 and 5.1).</p><p>Treatment should not be extended beyond 14 days without review.</p><p><strong><u>Adults and children &ge; 40 kg</u></strong></p><p>One tablet taken three times a day.</p><p><strong><u>Children &lt; 40 kg</u></strong></p><p><strong>Julmentin</strong> 250 mg/125 mg film-coated tablets are not recommended in children &lt; 40 kg.</p><p><strong><u>Elderly</u></strong></p><p>No dose adjustment is considered necessary.</p><p><strong><u>Renal impairment</u></strong></p><p>Dose adjustments are based on the maximum recommended level of amoxicillin.</p><p>No adjustment in dose is required in patients with creatinine clearance (CrCl) greater than 30 ml/min.</p><p><strong>Adults and children &ge; 40 kg</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:554px"><tbody><tr><td style="vertical-align:top"><p>CrCl: 10-30 ml/min</p></td><td style="vertical-align:top"><p>250 mg/125 mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p>CrCl &lt; 10 ml /min</p></td><td style="vertical-align:top"><p>250 mg/125 mg once daily</p></td></tr><tr><td style="vertical-align:top"><p>Haemodialysis</p></td><td style="vertical-align:top"><p>Two doses of 250 mg/125 mg every 24 hours, plus two doses of 250 mg/125 mg during dialysis, to be repeated at the end of dialysis (as serum concentrations of both amoxicillin and clavulanic acid are decreased)</p></td></tr></tbody></table><p><strong>Children &lt; 40 kg</strong></p><p>In children &lt; 40 kg with creatinine clearance less than 30 ml/min, the use of amoxicillin/clavulanic acid presentations with an amoxicillin to clavulanic acid ratio of 2:1 is not recommended, as no dose adjustments are available. In such patients, amoxicillin/clavulanic acid formulations with an amoxicillin to clavulanic acid ratio of 4:1 are recommended.</p><p><strong><u>Hepatic impairment</u></strong></p><p>Dose with caution and monitor hepatic function at regular intervals (see sections 4.3 and 4.4).</p><p><strong><u>Method of administration</u></strong></p><p><strong>Julmentin</strong> is for oral use.</p><p><strong>Julmentin</strong> should be administer with a meal to minimise potential gastrointestinal intolerance.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	Hypersensitivity to the active substances, to any of the penicillins or to any of the excipients listed in section 6.1.
	History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam).
	History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid (see section 4.8).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before initiating therapy with amoxicillin/clavulanic acid, careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins or other beta-lactam agents (see sections 4.3 and 4.8).&nbsp;</p><p>Serious and occasionally fatal hypersensitivity reactions (including anaphylactoid and severe cutaneous adverse have been reported in patients on penicillin therapy. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and in atopic individuals. If an allergic reaction occurs, amoxicillin/clavulanic acid therapy must be discontinued and appropriate alternative therapy instituted.</p><p>In the case that an infection is proven to be due to an amoxicillin-susceptible organisms(s) then consideration should be given to switching from amoxicillin/clavulanic acid to amoxicillin in accordance with official guidance.</p><p>This presentation of amoxicillin/clavulanic acid is not suitable for use when there is a high risk that the presumptive pathogens have reduced susceptibility or resistance to beta-lactam agents that is not mediated by beta-lactamases susceptible to inhibition by clavulanic acid (e.g. penicillin-insusceptible&nbsp;<em>S. pneumoniae</em>).</p><p>Convulsions may occur in patients with impaired renal function or in those receiving high doses (see section 4.8).</p><p>Amoxicillin/clavulanic acid should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform rash has been associated with this condition following the use of amoxicillin.</p><p>Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions.</p><p>Prolonged use may occasionally result in overgrowth of non-susceptible organisms.</p><p>The occurrence at the treatment initiation of a feverish generalised erythema associated with pustula may be a symptom of acute generalised exanthemous pustulosis (AGEP) (see Section 4.8). This reaction requires amoxicillin/clavulanic acid discontinuation and contra-indicates any subsequent administration of amoxicillin.</p><p>Amoxicillin/clavulanic acid should be used with caution in patients with evidence of hepatic impairment (see sections 4.2, 4.3 and 4.8).</p><p>Hepatic events have been reported predominantly in males and elderly patients and may be associated with prolonged treatment. These events have been very rarely reported in children. In all populations, signs and symptoms usually occur during or shortly after treatment but in some cases may not become apparent until several weeks after treatment has ceased. These are usually reversible. Hepatic events may be severe and, in extremely rare circumstances, deaths have been reported. These have almost always occurred in patients with serious underlying disease or taking concomitant medications known to have the potential for hepatic effects (see section 4.8).</p><p>Antibiotic-associated colitis has been reported with nearly all antibacterial agents and may range in severity from mild to life threatening (see section 4.8). Therefore, it is important to consider this diagnosis in patients who present with diarrhoea during or subsequent to the administration of any antibiotics. Should antibiotic-associated colitis occur, amoxicillin/clavulanic acid should immediately be discontinued, a physician be consulted and an appropriate therapy initiated. Anti-peristaltic medicinal products are contra-indicated in this situation.</p><p>Periodic assessment of organ system functions, including renal, hepatic and haematopoietic function is advisable during prolonged therapy.</p><p>Prolongation of prothrombin time has been reported rarely in patients receiving amoxicillin/clavulanic acid. Appropriate monitoring should be undertaken when anticoagulants are prescribed concomitantly. Adjustments in the dose of oral anticoagulants may be necessary to maintain the desired level of anticoagulation (see section 4.5 and 4.8).</p><p>In patients with renal impairment, the dose should be adjusted according to the degree of impairment (see section 4.2).</p><p>In patients with reduced urine output, crystalluria has been observed very rarely, predominantly with parenteral therapy. During the administration of high doses of amoxicillin, it is advisable to maintain adequate fluid intake and urinary output in order to reduce the possibility of amoxicillin crystalluria. In patients with bladder catheters, a regular check of patency should be maintained (see section 4.9).</p><p>During treatment with amoxicillin, enzymatic glucose oxidase methods should be used whenever testing for the presence of glucose in urine because false positive results may occur with non-enzymatic methods.</p><p>The presence of clavulanic acid in the tablets may cause a non-specific binding of IgG and albumin by red cell membranes leading to a false positive Coombs test.</p><p>There have been reports of positive test results using the Bio-Rad Laboratories Platelia&nbsp;<em>Aspergillus</em>&nbsp;EIA test in patients receiving amoxicillin/clavulanic acid who were subsequently found to be free of&nbsp;<em>Aspergillus</em>&nbsp;infection. Cross-reactions with non-<em>Aspergillus</em>&nbsp;polysaccharides and polyfuranoses with Bio-Rad Laboratories Platelia&nbsp;<em>Aspergillus</em>&nbsp;EIA test have been reported. Therefore, positive test results in patients receiving amoxicillin/clavulanic acid should be interpreted cautiously and confirmed by other diagnostic methods.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Oral anticoagulants</u></strong></p><p>Oral anticoagulants and penicillin antibiotics have been widely used in practice without reports of interaction. However, in the literature there are cases of increased international normalised ratio in patients maintained on acenocoumarol or warfarin and prescribed a course of amoxicillin. If co-administration is necessary, the prothrombin time or international normalised ratio should be carefully monitored with the addition or withdrawal of amoxicillin. Moreover, adjustments in the dose of oral anticoagulants may be necessary (see section 4.4 and 4.8).</p><p><strong><u>Methotrexate</u></strong><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p>Penicillins may reduce the excretion of methotrexate causing a potential increase in toxicity.</p><p><strong><u>Probenecid</u></strong></p><p>Concomitant use of probenecid is not recommended. Probenecid decreases the renal tubular secretion of amoxicillin. Concomitant use of probenecid may result in increased and prolonged blood levels of amoxicillin but not of clavulanic acid.</p><p><strong><u>Mycophenolate mofetil</u></strong></p><p>In patients receiving mycophenolate mofetil, reduction in pre-dose concentration of the active metabolite mycophenolic acid (MPA) of approximately 50% has been reported following commencement of oral amoxicillin plus clavulanic acid. The change in pre-dose level may not accurately represent changes in overall MPA exposure. Therefore, a change in the dose of mycophenolate mofetil should not normally be necessary in the absence of clinical evidence of graft dysfunction. However, close clinical monitoring should be performed during the combination and shortly after antibiotic treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Pregnancy</u></strong></p><p>Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development (see section 5.3). Limited data on the use of amoxicillin/clavulanic acid during pregnancy in humans do not indicate an increased risk of congenital malformations. In a single study in women with preterm, premature rupture of the foetal membrane it was reported that prophylactic treatment with amoxicillin/clavulanic acid may be associated with an increased risk of necrotising enterocolitis in neonates. Use should be avoided during pregnancy, unless considered essential by the physician.</p><p><strong><u>Breastfeeding</u></strong></p><p>Both substances are excreted into breast milk (nothing is known of the effects of clavulanic acid on the breast-fed infant). Consequently, diarrhoea and fungus infection of the mucous membranes are possible in the breast-fed infant, so that breast-feeding might have to be discontinued. The possibility of sensitisation should be taken into account. Amoxicillin/clavulanic acid should only be used during breast-feeding after benefit/risk assessment by the physician in charge.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed. However, undesirable effects may occur (e.g. allergic reactions, dizziness, convulsions), which may influence the ability to drive and use machines (see section 4.8).</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported adverse drug reactions (ADRs) are diarrhoea, nausea and vomiting.</p><p>The ADRs derived from clinical studies and post-marketing surveillance with amoxicillin/clavulanic acid, sorted by MedDRA System Organ Class are listed below.</p><p>The following terminologies have been used in order to classify the occurrence of undesirable effects.</p><p>&sect; Very common (&ge;1/10)</p><p>&sect; Common (&ge;1/100 to &lt;1/10)</p><p>&sect; Uncommon (&ge;1/1,000 to &lt;1/100)</p><p>&sect; Rare (&ge;1/10,000 to &lt;1/1,000)</p><p>&sect; Very rare (&lt;1/10,000)</p><p>&sect; Not known (cannot be estimated from the available data)</p><table border="1" cellspacing="0" cellpadding="0" style="width:546px"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Infections and infestations</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Mucocutaneous candidosis</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Overgrowth of non-susceptible organisms</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Blood and lymphatic system disorders</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Reversible leucopenia (including neutropenia)</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Thrombocytopenia</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Reversible agranulocytosis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Haemolytic anaemia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Prolongation of bleeding time and prothrombin time<sup>1</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Immune system disorders</u></strong><strong><sup>10</sup></strong></p></td></tr><tr><td style="vertical-align:top"><p>Angioneurotic oedema</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Anaphylaxis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Serum sickness-like syndrome</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Hypersensitivity vasculitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Nervous system disorders</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Dizziness</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Headache</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Reversible hyperactivity</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Convulsions<sup>2</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Aseptic meningitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>&nbsp;</u></strong></p><p><strong><u>Gastrointestinal disorders</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhoea</p></td><td style="vertical-align:top"><p>Very common</p></td></tr><tr><td style="vertical-align:top"><p>Nausea<sup>3</sup></p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Vomiting</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Indigestion</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Antibiotic-associated colitis<sup>4</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Black hairy tongue</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Hepatobiliary disorders</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Rises in AST and/or ALT<sup>5</sup></p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Hepatitis<sup>6</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cholestatic jaundice<sup>6</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Skin and subcutaneous tissue disorders&nbsp;</u></strong><strong><sup>7</sup></strong></p></td></tr><tr><td style="vertical-align:top"><p>Skin rash</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Pruritus</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Urticaria</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Erythema multiforme</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Stevens-Johnson syndrome</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Toxic epidermal necrolysis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Bullous exfoliative-dermatitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Acute generalised exanthemous pustulosis (AGEP)<sup>9</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Drug reaction with eosinophilia and systemic symptoms (DRESS)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Renal and urinary disorders</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Interstitial nephritis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Crystalluria<sup>8</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><sup>1</sup>&nbsp;See section 4.4</p><p><sup>2</sup>&nbsp;See section 4.4.</p><p><sup>3</sup>&nbsp;Nausea is more often associated with higher oral doses. If gastrointestinal reactions are evident, they may be reduced by taking amoxicillin/clavulanic acid with a meal.</p><p><sup>4&nbsp;</sup>Including pseudomembranous colitis and haemorrhagic colitis (see section 4.4)</p><p><sup>5</sup>&nbsp;A moderate rise in AST and/or ALT has been noted in patients treated with beta-lactam class antibiotics, but the significance of these findings is unknown.</p><p><sup>6&nbsp;</sup>These events have been noted with other penicillins and cephalosporins (see section 4.4).</p><p><sup>7</sup>&nbsp;If any hypersensitivity dermatitis reaction occurs, treatment should be discontinued (see section 4.4).</p><p><sup>8</sup>&nbsp;See section 4.9</p><p><sup>9</sup>&nbsp;See section 4.4</p><p><sup>10</sup>&nbsp;See sections 4.3 and 4.4</p></td></tr></tbody></table><p><strong><u>To report any side effect(s):</u></strong></p><p>&sect; <strong>Saudi Arabia:</strong></p><p>The National Pharmacovigilance Centre (NPC):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Centre: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p><p>&sect; <strong>Other GCC States: </strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Symptoms and signs of overdose</u></strong></p><p>Gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident. Amoxicillin crystalluria, in some cases leading to renal failure, has been observed (see section 4.4).</p><p>Convulsions may occur in patients with impaired renal function or in those receiving high doses.</p><p>Amoxicillin has been reported to precipitate in bladder catheters, predominantly after intravenous administration of large doses. A regular check of patency should be maintained (see section 4.4)</p><p><strong><u>Treatment of intoxication</u></strong></p><p>Gastrointestinal symptoms may be treated symptomatically, with attention to the water/electrolyte balance.</p><p>Amoxicillin/clavulanic acid can be removed from the circulation by haemodialysis.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong> Combinations of penicillins, incl. beta-lactamase inhibitors; ATC code: J01CR02.</p><p><strong><u>Mechanism of action</u></strong></p><p>Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bacterial peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.</p><p>Amoxicillin is susceptible to degradation by beta-lactamases produced by resistant bacteria and therefore the spectrum of activity of amoxicillin alone does not include organisms which produce these enzymes.</p><p>Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin. Clavulanic acid alone does not exert a clinically useful antibacterial effect.</p><p><strong><u>Pharmacokinetic/Pharmacodynamic relationship</u></strong></p><p>The time above the minimum inhibitory concentration (T&gt;MIC) is considered to be the major determinant of efficacy for amoxicillin.</p><p><strong><u>Mechanisms of resistance</u></strong></p><p>The two main mechanisms of resistance to amoxicillin/clavulanic acid are:</p><p>&sect; Inactivation by those bacterial beta-lactamases that are not themselves inhibited by clavulanic acid, including class B, C and D.</p><p>&sect; Alteration of PBPs, which reduce the affinity of the antibacterial agent for the target.</p><p>Impermeability of bacteria or efflux pump mechanisms may cause or contribute to bacterial resistance, particularly in Gram-negative bacteria.</p><p><strong><u>Breakpoints&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u></strong></p><p>MIC breakpoints for amoxicillin/clavulanic acid are those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST).</p><table border="1" cellspacing="0" cellpadding="0" style="width:546px"><tbody><tr><td style="vertical-align:top"><p><strong>Organism</strong></p></td><td colspan="3" style="vertical-align:top"><p><strong>Susceptibility Breakpoints (&mu;g/ml)</strong></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p><strong>Susceptible</strong></p></td><td style="vertical-align:top"><p><strong>Intermediate</strong></p></td><td style="vertical-align:top"><p><strong>Resistant</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus influenzae</em><strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 1</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 1</p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis</em>&nbsp;<strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 1</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 1</p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus aureus&nbsp;</em><strong><sup>2</sup></strong></p></td><td style="vertical-align:top"><p>&le; 2</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 2</p></td></tr><tr><td style="vertical-align:top"><p>Coagulase-negative staphylococci&nbsp;<strong><sup>2</sup></strong></p></td><td style="vertical-align:top"><p>&le; 0.25</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>&gt; 0.25</p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus</em>&nbsp;<strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus A, B, C, G</em>&nbsp;<strong><sup>5</sup></strong></p></td><td style="vertical-align:top"><p>&le; 0.25</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 0.25</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae</em><strong><sup>3</sup></strong></p></td><td style="vertical-align:top"><p>&le; 0.5</p></td><td style="vertical-align:top"><p>1-2</p></td><td style="vertical-align:top"><p>&gt; 2</p></td></tr><tr><td style="vertical-align:top"><p>Enterobacteriaceae<strong><sup>1,4</sup></strong></p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td style="vertical-align:top"><p>Gram-negative Anaerobes<strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td style="vertical-align:top"><p>Gram-positive Anaerobes<strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td style="vertical-align:top"><p>Non-species related breakpoints<strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 2</p></td><td style="vertical-align:top"><p>4-8</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p><sup>1</sup>&nbsp;The reported values are for Amoxicillin concentrations. For susceptibility testing purposes, the concentration of Clavulanic acid is fixed at 2 mg/l.</p><p><sup>2</sup>&nbsp;The reported values are Oxacillin concentrations.</p><p><sup>3</sup>&nbsp;Breakpoint values in the table are based on Ampicillin breakpoints.</p><p><sup>4</sup>&nbsp;The resistant breakpoint of R&gt;8 mg/l ensures that all isolates with resistance mechanisms are reported resistant.</p><p><sup>5</sup>&nbsp;Breakpoint values in the table are based on Benzylpenicillin breakpoints.</p></td></tr></tbody></table><p>The prevalence of resistance may vary geographically and with time for selected species, and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><table border="1" cellspacing="0" cellpadding="0" style="width:554px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Commonly susceptible species</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive micro-organisms</u></p><p><em>Enterococcus faecalis</em></p><p><em>Staphylococcus aureus (</em>methicillin-susceptible)&pound;</p><p>Coagulase-negative staphylococci (methicillin-susceptible)</p><p><em>Streptococcus agalactiae</em></p><p><em>Streptococcus pneumoniae</em>&nbsp;<sup>1</sup></p><p><em>Streptococcus pyogenes</em>&nbsp;and other beta-hemolytic streptococci</p><p><em>Streptococcus viridans&nbsp;</em>group</p><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Capnocytophaga&nbsp;</em>spp.</p><p><em>Eikenella corrodens</em></p><p><em>Haemophilus influenzae</em>&nbsp;<sup>2</sup></p><p><em>Moraxella catarrhalis</em></p><p><em>Pasteurella multocida</em></p><p><u>Anaerobic micro-organisms</u></p><p><em>Bacteroides fragilis</em></p><p><em>Fusobacterium nucleatum</em></p><p><em>Prevotella</em>&nbsp;spp.</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Species for which acquired resistance may be a problem</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive micro-organisms</u></p><p><em>Enterococcus faecium&nbsp;</em>$</p><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Escherichia coli</em></p><p><em>Klebsiella oxytoca</em></p><p><em>Klebsiella pneumoniae</em></p><p><em>Proteus mirabilis</em></p><p><em>Proteus vulgaris</em></p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Inherently resistant organisms</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Acinetobacter&nbsp;</em>sp.</p><p><em>Citrobacter freundii</em></p><p><em>Enterobacter</em>&nbsp;sp.</p><p><em>Morganella morganii</em></p><p><em>Providencia&nbsp;</em>spp.</p><p><em>Pseudomonas&nbsp;</em>sp.</p><p><em>Serratia&nbsp;</em>sp.</p><p><em>Stenotrophomonas maltophilia</em></p></td></tr><tr><td style="vertical-align:top"><p>$ Natural intermediate susceptibility in the absence of acquired mechanism of resistance.</p><p>&pound;All methicillin-resistant staphylococci are resistant to amoxicillin/clavulanic acid</p><p><sup>1</sup><em>Streptococcus pneumoniae</em>&nbsp;that is fully susceptible to penicillin may be treated with this presentation of amoxicillin/clavulanic acid. Organisms that show any degree of reduced susceptibility to penicillin should not be treated with this presentation (see sections 4.2 and 4.4).</p><p><sup>2&nbsp;</sup>Strains with decreased susceptibility have been reported in some countries in the EU with a frequency higher than 10%.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Absorption</u></strong></p><p>Amoxicillin and clavulanic acid, are fully dissociated in aqueous solution at physiological pH. Both components are rapidly and well absorbed by the oral route of administration.</p><p>Following oral administration, amoxicillin and clavulanic acid are approximately 70% bioavailable. The plasma profiles of both components are similar and the time to peak plasma concentration (T<sub>max</sub>) in each case is approximately one hour.</p><p>The pharmacokinetic results for a study, in which amoxicillin/clavulanic acid (250 mg/125 mg tablets three times daily) was administered in the fasting state to groups of healthy volunteers, are presented below.</p><table border="1" cellspacing="0" cellpadding="0" style="width:548px"><tbody><tr><td colspan="6" style="vertical-align:top"><p><strong>Mean (&plusmn; SD) pharmacokinetic parameters</strong></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Active substance(s) administered</p></td><td style="vertical-align:top"><p>Dose</p></td><td style="vertical-align:top"><p>C<sub>max</sub></p></td><td style="vertical-align:top"><p>T<sub>max</sub>&nbsp;*</p></td><td style="vertical-align:top"><p>AUC&nbsp;<sub>(0-24h)</sub></p></td><td style="vertical-align:top"><p>T 1/2</p></td></tr><tr><td style="vertical-align:top"><p>(mg)</p></td><td style="vertical-align:top"><p>(&mu;g/ml)</p></td><td style="vertical-align:top"><p>(h)</p></td><td style="vertical-align:top"><p>((&mu;g.h/ml)</p></td><td style="vertical-align:top"><p>(h)</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>Amoxicillin</p></td></tr><tr><td style="vertical-align:top"><p>AMX/CA</p><p>250 mg/125 mg</p></td><td style="vertical-align:top"><p>250</p></td><td style="vertical-align:top"><p>3.3</p><p>&plusmn; 1.12</p></td><td style="vertical-align:top"><p>1.5</p><p>(1.0-2.0)</p></td><td style="vertical-align:top"><p>26.7&plusmn;4.56</p></td><td style="vertical-align:top"><p>1.36</p><p>&plusmn; 0.56</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>Clavulanic acid</p></td></tr><tr><td style="vertical-align:top"><p>AMX/CA</p><p>250 mg/125 mg</p></td><td style="vertical-align:top"><p>125</p></td><td style="vertical-align:top"><p>1.5</p><p>&plusmn; 0.70</p></td><td style="vertical-align:top"><p>1.2</p><p>(1.0-2.0)</p></td><td style="vertical-align:top"><p>12.6</p><p>&plusmn; 3.25</p></td><td style="vertical-align:top"><p>1.01</p><p>&plusmn; 0.11</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>AMX &ndash; amoxicillin, CA &ndash; clavulanic acid</p><p>* Median (range)</p></td></tr></tbody></table><p>Amoxicillin and clavulanic acid serum concentrations achieved with amoxicillin/clavulanic acid are similar to those produced by the oral administration of equivalent doses of amoxicillin or clavulanic acid alone.</p><p><strong><u>Distribution</u></strong></p><p>About 25% of total plasma clavulanic acid and 18% of total plasma amoxicillin is bound to protein. The apparent volume of distribution is around 0.3-0.4 l/kg for amoxicillin and around 0.2 l/kg for clavulanic acid.</p><p>Following intravenous administration, both amoxicillin and clavulanic acid have been found in gall bladder, abdominal tissue, skin, fat, muscle tissues, synovial and peritoneal fluids, bile and pus. Amoxicillin does not adequately distribute into the cerebrospinal fluid.</p><p>From animal studies there is no evidence for significant tissue retention of drug-derived material for either component. Amoxicillin, like most penicillins, can be detected in breast milk. Trace quantities of clavulanic acid can also be detected in breast milk (see section 4.6).</p><p>Both amoxicillin and clavulanic acid have been shown to cross the placental barrier (see section 4.6).</p><p><strong><u>Biotransformation</u></strong></p><p>Amoxicillin is partly excreted in the urine as the inactive penicilloic acid in quantities equivalent to up to 10 to 25% of the initial dose. Clavulanic acid is extensively metabolized in man and eliminated in urine and faeces and as carbon dioxide in expired air.</p><p><strong><u>Elimination</u></strong></p><p>The major route of elimination for amoxicillin is via the kidney, whereas for clavulanic acid it is by both renal and non-renal mechanisms.</p><p>Amoxicillin/clavulanic acid has a mean elimination half-life of approximately one hour and a mean total clearance of approximately 25 l/h in healthy subjects. Approximately 60 to 70% of the amoxicillin and approximately 40 to 65% of the clavulanic acid are excreted unchanged in urine during the first 6 h after administration of single amoxicillin/clavulanic acid 250 mg/125 mg or 500 mg/125 mg tablets. Various studies have found the urinary excretion to be 50-85% for amoxicillin and between 27-60% for clavulanic acid over a 24 hour period. In the case of clavulanic acid, the largest amount of drug is excreted during the first 2 hours after administration.</p><p>Concomitant use of probenecid delays amoxicillin excretion but does not delay renal excretion of clavulanic acid (see section 4.5).</p><p><strong><u>Age</u></strong></p><p>The elimination half-life of amoxicillin is similar for children aged around 3 months to 2 years and older children and adults. For very young children (including preterm newborns) in the first week of life the interval of administration should not exceed twice daily administration due to immaturity of the renal pathway of elimination. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</p><p><strong><u>Gender</u></strong></p><p>Following oral administration of amoxicillin/clavulanic acid to healthy males and female subjects, gender has no significant impact on the pharmacokinetics of either amoxicillin or clavulanic acid.</p><p><strong><u>Renal impairment</u></strong></p><p>The total serum clearance of amoxicillin/clavulanic acid decreases proportionately with decreasing renal function. The reduction in drug clearance is more pronounced for amoxicillin than for clavulanic acid, as a higher proportion of amoxicillin is excreted&nbsp;<em>via&nbsp;</em>the renal route. Doses in renal impairment must therefore prevent undue accumulation of amoxicillin while maintaining adequate levels of clavulanic acid (see section 4.2).</p><p><strong><u>Hepatic impairment</u></strong></p><p>Hepatically impaired patients should be dosed with caution and hepatic function monitored at regular intervals.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on studies of safety pharmacology, genotoxicity and toxicity to reproduction.</p><p>Repeat dose toxicity studies performed in dogs with amoxicillin/clavulanic acid demonstrate gastric irritancy and vomiting, and discoloured tongue.</p><p>Carcinogenicity studies have not been conducted with amoxicillin/clavulanic acid.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:581px"><tbody><tr><td style="vertical-align:top"><table border="0" cellspacing="0" cellpadding="0" style="width:526px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p><strong><u>Inactive Ingredients: </u></strong></p></td><td colspan="3" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Colloidal silicon dioxide (Aerosil-200)</p></td><td colspan="3"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Crospovidone (Kollidon CL)</p></td><td colspan="3"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Croscarmellose sodium (Ac-Di-Sol)</p></td><td colspan="3"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Magnesium stearate</p></td><td colspan="3"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Microcrystalline cellulose (Avicel PH-112)</p></td><td colspan="3"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>&nbsp;</p></td><td><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p><strong><u>Coating Materials: </u></strong></p></td><td colspan="2"><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Hydroxypropyl cellulose (Klucel EF)</p></td><td colspan="2"><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Ethyl cellulose</p></td><td colspan="2"><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>PVP K 25</p></td><td colspan="2"><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Triacetin&nbsp;</p></td><td colspan="2"><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Titanium dioxide</p></td><td colspan="2"><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Talc fine powder</p></td><td colspan="2"><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Polishing emulsion&nbsp;</p></td><td colspan="2"><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Absolute alcohol*</p></td><td colspan="2"><p>&nbsp;</p></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>*Evaporates during drying process</p></td></tr><tr><td style="vertical-align:top"><p>q.s: quantity sufficient</p><p>&nbsp;</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months from the date of manufacturing.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30<sup>o</sup>C, in a dry place</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>4 x 5&rsquo;s tablets in Desiccated cold forming -dry&nbsp;Aluminium&nbsp;foil, packed in a printed carton along with a leaflet.</p><p>3 x 5&rsquo;s tablets in Desiccated cold forming -dry&nbsp;Aluminium&nbsp;foil, packed in a printed carton along with a leaflet.</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street
Ras Al Khaimah - United Arab Emirates
P.O. Box 997
Tel. No.:   (9717) 2 461 461
Fax No.:   (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10. June. 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>